Ibuprofen Reduces Risk Of Death From Lung Cancer Among Former And Current Smokers, Researchers Say
Ibuprofen is known to reduce pain, fevers, and inflammation, but might also have a startling new application as well. Study findings presented at the IASLC 17th World Conference on Lung Cancer (WCLC) in Vienna, Austria indicated that regular use of ibuprofen might also reduce the risk of dying from lung cancer. This possible benefit appears to apply to both former smokers and current smokers. The researchers involved in the study suggested that regular ibuprofen use might actually lower the risk of lung cancer death.
Dr. Marisa Bittoni, from Ohio State University, and fellow researchers analyzed data of 10,735 adults who participated in the Third National Health and Nutrition Examination Survey (NHANES III). The idea that ibuprofen use might reduce risks associated with smoking wasn’t chosen out of the blue. Earlier studies had associated inflammation with an increased risk of lung cancer. Might the regular use of an anti-inflammatory medication have an effect? Bittoni and fellow researchers set out to investigate just that.
The team looked at the subject’s use of ibuprofen and other nonsteroidal anti-inflammatory drugs (NSAIDs), their smoking status, and other lifestyle factors. The participants followed up for an average of almost two decades while participating in the NHANES III. The researchers examined their cause-specific mortality status by using information from the National Death Index up until 2006. Using Cox proportional hazards regression models (which models the number of new cases of disease per population at-risk per unit time, according to a Penn State tutorial), the team estimated how NSAID use might be associated with the risk of dying from lung cancer.
Click here to continue and read more...
Ibuprofen Reduces Risk Of Death From Lung Cancer Among Former And Current Smokers, Researchers Say is an article from: The Inquisitr News
